首页> 外文期刊>Archives of medical research >Frequency of protease and reverse transcriptase drug resistance mutations in naive HIV-infected patients.
【24h】

Frequency of protease and reverse transcriptase drug resistance mutations in naive HIV-infected patients.

机译:初次感染HIV的患者中蛋白酶和逆转录酶耐药性突变的频率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Infections with drug-resistant HIV viruses in naive subjects may cause antiretroviral (ARV) treatment failure. The prevalence of ARV resistance mutations in HIV-1 transcripts of infected naive patients from northeast Mexico was determined in this study. METHODS: RNA was extracted from plasma samples of 42 naive individuals who were diagnosed between February 2001 and September 2003 as HIV-1 infected. Both protease (Pr) and reverse transcriptase (RT) were sequenced in 30 patients. In six samples only the RT segment was sequenced and in three samples only the protease segment was analyzed. RESULTS: One of 36 isolates (2.8%) had the M184V resistance mutation to nucleoside retrotranscriptase inhibitors. In the Pr segment, only minor mutations were detected in 27/33 isolates (81.8%). CONCLUSIONS: In this first study, prevalence of major mutations associated with ARV resistance in naive patients in northeast Mexico is low compared to other countries, perhaps due to a low level of exposure of thispopulation to ARV drugs.
机译:背景:在天真的受试者中感染抗药性HIV病毒可能会导致抗逆转录病毒(ARV)治疗失败。在这项研究中,确定了感染墨西哥东北部的未感染患者的HIV-1转录本中ARV耐药性突变的患病率。方法:从2001年2月至2003年9月之间被诊断为HIV-1感染的42位幼稚个体的血浆样品中提取RNA。对30例患者的蛋白酶(Pr)和逆转录酶(RT)进行了测序。在六个样品中,仅RT片段被测序,在三个样品中,仅蛋白酶片段被分析。结果:36个分离株中的1个(占2.8%)对核苷逆转录酶抑制剂具有M184V抗性突变。在Pr区段中,在27/33个分离物中仅检测到较小的突变(81.8%)。结论:在这项第一项研究中,与其他国家相比,墨西哥东北部幼稚患者中与ARV耐药相关的主要突变的患病率较低,这可能是由于该人群对ARV药物的接触水平较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号